Tag: https://www.bio.org/events/bio-international-convention

Jun 22
BIO's Policy Pulse: Phyllis Arthur Testifies on Need to Reauthorize PAHPA, Pass PASTEUR Act

The House Energy & Commerce Health Subcommittee held a hearing, Legislative Solutions to Bolster Preparedness and … source

Jun 21
How IRA Would Disincentivize Rare Disease R&D – House Energy & Commerce Committee Hearing

Rep. John Joyce (R-PA), a physician, and Dr. Alexis Thompson, Chief of Division of Hematology at the Children’s Hospital of Philadelphia, discuss how the Inflation Reduction Act (IRA) will hinder innovation in the treatment of rare diseases, at a legislative hearing of the House Energy & Commerce Health Subcommittee, on June 14, 2013. source

Jun 20
Peter Pellerito Shares His Top Takeaways from the BIO 2023 Best Practices Report

BIO released its seventh-annual best practices report, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, … source

Jun 09
Senate HELP Committee Hearing on PBMs and House W&M Health Subcommittee Hearing on Innovation

Senator Markwayne Mullin criticizes PBMs at the Senate Committee on Health, Education, Labor and Pensions (HELP) Hearing on “The Need to Make Insulin Affordable for All Americans,” and Rep. Kevin Hern discusses orphan drugs and innovation at the House Ways and Means Committee Health Subcommittee Hearing on “Examining Policies that Inhibit Innovation and Patient Access”. […]

Jun 08
Sen. Mullin Criticizes PBMs at Senate Committee on Health, Education, Labor and Pensions Hearing

Senator Markwayne Mullin criticizes PBMs at the Senate Committee on Health, Education, Labor and Pensions (HELP) Hearing on “The Need to Make Insulin Affordable for All Americans.” Wednesday, May 10, 2023 source